13F-HR filed by First Turn Management, LLC
First Turn Management, LLC filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-07, with 38 holding rows worth $631,607,289.
- Accession
- 0001085146-24-005432
- Filer
- CIK 1993440
- Filed
- 2024-11-07
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 38 entries on the cover page, a total value of $631,607,289 stated on the cover page (in dollars after the unit check, H1), rows summing to $631,607,289 with VALUE read as dollars as filed, 13F file number 028-23631. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NUVALENT INC COM | 670703107 | Stock | 359,114 | $36,737,362 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 54,440 | $29,510,835 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 356,451 | $26,020,923 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 647,611 | $25,256,829 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 211,985 | $24,223,526 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 255,294 | $22,943,272 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,187,165 | $22,852,926 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 150,593 | $22,485,041 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 155,650 | $19,759,768 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 254,800 | $18,643,716 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 353,376 | $18,057,514 | dollars as filed | |
| TRANSMEDICS GROUP INC | 89377M109 | COM | 114,247 | $17,936,779 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 214,298 | $17,896,026 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 178,929 | $16,550,933 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 572,928 | $16,483,139 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 35,222 | $16,381,048 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 315,816 | $15,781,326 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 357,003 | $15,447,520 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 308,014 | $15,388,379 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,451,037 | $14,873,129 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 30,254 | $14,862,883 | dollars as filed | |
| HARROW INC | 415858109 | COM | 326,582 | $14,683,127 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 326,494 | $14,431,035 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 562,391 | $14,324,099 | dollars as filed | |
| GERON CORP | 374163103 | COM | 3,124,967 | $14,187,350 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 535,092 | $13,666,250 | dollars as filed | |
| ADMA BIOLOGICS INC | 000899104 | COM | 664,985 | $13,293,050 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 947,878 | $13,203,941 | dollars as filed | |
| REPLIGEN CORP COM | 759916109 | Stock | 88,714 | $13,202,417 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 325,218 | $12,803,833 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 96,097 | $12,519,517 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 67,942 | $12,367,482 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 223,147 | $11,782,162 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 621,306 | $11,475,522 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 399,781 | $10,178,424 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 1,226,354 | $8,682,586 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 593,291 | $8,602,720 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 355,000 | $4,110,900 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-24-005432 | this filing | 2024-11-07 | acceptance time not in the bulk data set |